Riskpilot← Back to searchSign inGet full accessAPOTEK 1 GRUPPEN AS
ASActiveOrg 983044778Skårersletta 55, 1473 LørenskogRetail sale of pharmaceutical products · NACE 4773Est. 20016980 employeeswww.apotek1.no
Revenue 2025
NOK 19,6B
+11% vs 2024
EBITDA margin
7.2%
+4% vs 2024
Equity ratio
9.1%
Financial strength
Net profit 2025
NOK 838,6M
+2% vs 2024
| Revenue | NOK 19,6B | +11% |
| EBITDA | NOK 1,4B | +4% |
| Net profit | NOK 838,6M | +2% |
| Total assets | NOK 7,1B | +2% |
| Equity | NOK 642,1M | +26% |
| Employees | 6980 | — |
Legal name
APOTEK 1 GRUPPEN AS
Org number
983044778
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
22. februar 2001
Share capital
NOK 100 000 000
Employees
6980 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Organisere, eie opg drive apotek, lignende detaljomsetning og grossistvirksomhet for legemidler og lignende produkter og all annen virksomhet som hører med til dette, herunder kjøp og salg av virksomhet og utstedelse av garantier i forbindelse med egen virksomhet.
Address
Skårersletta 55, 1473 Lørenskog
Phone
+4721611000
Email
kontakt@apotek1.no
Website
www.apotek1.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 13 109 712 | 14 525 201 | 15 406 466 | 17 734 722 | 19 647 530 |
| Staff expenses | −2 480 547 | −2 725 130 | −2 897 969 | −3 185 013 | −3 370 432 |
| EBITDA | 904 601 | 997 523 | 1 020 366 | 1 366 155 | 1 420 501 |
| Depreciation & amort. | −282 088 | −272 350 | −258 577 | −257 940 | −302 768 |
| EBIT | 622 513 | 725 173 | 761 789 | 1 108 215 | 1 117 733 |
| Net financials | −28 635 | −28 936 | −3 695 | −39 030 | −28 158 |
| Profit before tax | 593 879 | 696 236 | 758 094 | 1 069 185 | 1 089 575 |
| Tax | 134 455 | 158 802 | 185 319 | 249 942 | 250 978 |
| Net profit | 459 423 | 537 435 | 572 775 | 819 243 | 838 597 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 632 861 | 6 312 063 | 6 161 746 | 6 949 257 | 7 090 018 |
| Equity | 622 183 | 555 785 | 436 916 | 508 284 | 642 121 |
| Long-term debt | 79 990 | 70 154 | 51 626 | 47 666 | 39 305 |
| Short-term debt | 4 930 688 | 5 686 123 | 5 673 203 | 6 393 306 | 6 408 592 |
| Total debt | 5 010 678 | 5 756 277 | 5 724 829 | 6 440 973 | 6 447 897 |
EBITDA margin
7.2%
This company
15.8%
Market median
-54% vs market
20212025
Equity ratio
9.1%
This company
38.2%
Market median
-76% vs market
20212025
Return on equity
130.6%
This company
18.4%
Market median
+610% vs market
20212025
Net profit margin
4.3%
This company
8.1%
Market median
-47% vs market
20212025
Asset turnover
2.77×
This company
1.12×
Market median
+147% vs market
20212025
Debt / equity
10.04×
This company
0.62×
Market median
-1519% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2024-02-01 – 2025-01-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-02-01 – 2024-01-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-02-01 – 2023-01-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-02-01 – 2022-01-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-02-01 – 2021-01-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
JI Chief Executive Officer | Chief Executive Officer | 2026 |
WM Deputy Member | Deputy Member | 2026 |
HM Deputy Member | Deputy Member | 2026 |
SP Deputy Member | Deputy Member | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (8) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2026 | |
| Board of Directors | 2025 | |
| Board of Directors | 2026 | |
| Board of Directors | 2022 | |
| Board of Directors | 2025 | |
| Former (5) | ||
| Chairman | 2022 – 2022 | |
| Chairman | 2017 – 2022 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Phoenix Norwegian Holding As
APOTEK 1 GRUPPEN AS Board members of APOTEK 1 GRUPPEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jaan Ivar Gjærum Semlitsch | Chief Executive Officer | 0 companies |
| Wilhelm Marius Støren Castberg | Deputy Member | 0 companies |
| Hafiz Muhammad Nawaz Afzal | Deputy Member | 0 companies |
| Sairan Palani | Deputy Member | 0 companies |
| Ingun Gjerde | Board of Directors | 0 companies |
| Ann-Karin Berggren | Board of Directors | 0 companies |
| Anne-Lie Therese Lind | Chairman | 0 companies |
| Øyvind Andreas Winther | Chairman | 0 companies |
| Muhammad Shakil | Board of Directors | 0 companies |
| Lars Ove Håkan Schenatz | Chairman | 0 companies |
| Karin Flom | Board of Directors | 0 companies |
| Hilde Baekken Drevland | Board of Directors | 0 companies |
| Monika Jorid Annbjørg Nilsen | Board of Directors | 0 companies |
| Børge Moholt | Board of Directors | 0 companies |
| Grete Solberg | Board of Directors | 0 companies |
| Øystein Askim | Board of Directors | 0 companies |
| Christian Ekstrøm | Board of Directors | 0 companies |